remibrutinib
novartis
['remibrutinib', 'louisse']
 the louisse study in primary #sj gren s syndrome new drug class
remibrutinib, a btki n=73, dbpcrct, 24 weeks significantly improved essdai (organ involvement) but did not improve esspri (#pro) #acr22 #medtwitter #rheumtwitter 
Rheumatologist, Internist MRCP FAMS @NUHS @NUSingapore ???? MBBS,MD @AIIMS_NewDelhi ???? || Mummy of 2 || Dreamer || #MedEd || Views my own.